We evaluated soluble markers of IFN signaling and liver cirrhosis, plasma miRNAs and other non-coding RNAs as well as PBMC RNA in the longitudinal setting of HCV DAA therapy prior to diagnosis of HCC to understand factors involved in the early stages of HCC pathogenesis. The gene discussed is IFNA1; the disease is hepatocellular carcinoma.